InflaRx
IFRX
39 hedge funds and large institutions have $29.3M invested in InflaRx in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 8 closing their positions.
722% more call options, than puts
Call options by funds: $74K | Put options by funds: $9K
1.75% less ownership
Funds ownership: 32.32% → 30.57% (-1.7%)
7% less funds holding
Funds holding: 42 → 39 (-3)
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
48% less capital invested
Capital invested by funds: $56.8M → $29.3M (-$27.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$2.08M |
| 2 |
Citigroup
New York
|
+$2.06M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$268K |
| 4 |
Millennium Management
New York
|
+$254K |
| 5 |
Two Sigma Investments
New York
|
+$216K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
-$2.54M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.63M |
| 3 |
EP
Eversept Partners
New York
|
-$741K |
| 4 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$596K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$589K |
IFRX Hedge Fund Activity: Q4 2023 in Review
39 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q4 2023, worth a combined $29.3M — down 48% from $56.8M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of IFRX and 5 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 11 added.
The largest buyer was Morgan Stanley, adding an estimated $2.08M. The largest seller was 683 Capital Management, cutting an estimated $2.54M.
- 39 institutional investors held InflaRx (IFRX) as of Q4 2023, down from 42 in Q3 2023.
- Funds reported $29.3M of InflaRx stock for Q4 2023, down 48% quarter-over-quarter.
- 5 funds opened new InflaRx positions in Q4 2023 and 8 closed out, a net change of -3 holders.
- The largest InflaRx buyer in Q4 2023 was Morgan Stanley, an estimated $2.08M added.
- The largest InflaRx seller in Q4 2023 was 683 Capital Management, an estimated $2.54M sold.
Based on aggregated 13F filings for Q4 2023.